• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $VMD

    Viemed Healthcare Inc.

    Subscribe to $VMD
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.

    IPO Year:

    Exchange: NASDAQ

    Website: viemed.com

    Recent Analyst Ratings for Viemed Healthcare Inc.

    DatePrice TargetRatingAnalyst
    11/3/2021$13.00 → $9.00Outperform
    RBC Capital
    See more ratings

    Viemed Healthcare Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Heltz Sabrina bought $19,977 worth of shares (2,820 units at $7.08), increasing direct ownership by 7% to 41,040 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      5/14/24 5:25:11 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

      LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced it will present at the East Coast IDEAS Investor Conference on Wednesday June 11, 2025 at The Westin Times Square in New York, NY. Viemed's presentation is scheduled to begin at 11:30am ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the Company's website: http://viemed.com/investors. ABOUT VIEMED HEALTHCARE, INC. Viemed is an

      6/3/25 8:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces First Quarter 2025 Financial Results

      LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

      5/7/25 4:45:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

      LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment ("Lehan"), a healthcare company offering home medical equipment with specialties in respiratory care and women's health. "Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women's health and a deep commitment to community engagement," said Viemed Chief

      5/6/25 8:30:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

      LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: (866) 682-6100 (US Toll-Free) +1 (862) 298-0702 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=0dOJVhdb Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIE

      4/22/25 4:30:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Record 2024 Financial Results

      LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended Decembe

      3/10/25 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Year End 2024 Earnings Conference Call Details

      LAFAYETTE, La., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its Year End 2024 earnings conference call on Tuesday, March 11, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=TPQeuTNd Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIEMED HEAL

      2/25/25 8:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Third Quarter 2024 Financial Results

      LAFAYETTE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2024. Operational highlights (all dollar amounts are USD; comparisons are to the period ended September 30, 2023 unless otherwise noted): Net revenues increased 17.4% for the quarter ended September 30, 2024 to $58.0 million, setting another Company record, and increased 5.5% sequentially over the second quarter ended June 30, 2024. Excluding acquired revenue of $1.1 million

      11/6/24 4:45:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Third Quarter 2024 Earnings Conference Call Details

      LAFAYETTE, La., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its third quarter 2024 earnings conference call on Thursday, November 7, 2024, at 12:00 p.m. EST. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=qSIpA5NC Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

      10/22/24 8:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Record Second Quarter 2024 Financial Results

      LAFAYETTE, La., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2024 reached a new Company record of $55.0 million, representing an increase of $11.7 million, or 27%, over net revenues reported for the comparable quarter ended June 30, 2023. This represents 9% sequential growth in revenue over the first quarter ended March 31, 2024. Ne

      8/7/24 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Date and Time for Conference Call

      LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 8, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 888-437-3179 (US Toll-Free)+1 862-298-0702 (International) Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Wednesday, August 7, 2024. Live Audio Webcast: https://event.choruscall.co

      7/24/24 9:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. SEC Filings

    See more
    • Viemed Healthcare Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      6/5/25 5:15:49 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 10-Q filed by Viemed Healthcare Inc.

      10-Q - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      5/7/25 4:50:18 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      5/7/25 4:47:49 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      5/6/25 8:34:09 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Viemed Healthcare Inc.

      SCHEDULE 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      4/29/25 3:48:44 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form DEFA14A filed by Viemed Healthcare Inc.

      DEFA14A - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      4/25/25 8:47:16 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form DEF 14A filed by Viemed Healthcare Inc.

      DEF 14A - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      4/25/25 8:45:57 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Viemed Healthcare Inc.

      SCHEDULE 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      4/23/25 7:22:14 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      4/14/25 4:29:42 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

      3/18/25 4:26:24 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. Financials

    Live finance-specific insights

    See more
    • Viemed Healthcare Announces First Quarter 2025 Financial Results

      LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

      5/7/25 4:45:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

      LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: (866) 682-6100 (US Toll-Free) +1 (862) 298-0702 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=0dOJVhdb Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIE

      4/22/25 4:30:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Record 2024 Financial Results

      LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended Decembe

      3/10/25 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Year End 2024 Earnings Conference Call Details

      LAFAYETTE, La., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its Year End 2024 earnings conference call on Tuesday, March 11, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=TPQeuTNd Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIEMED HEAL

      2/25/25 8:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Third Quarter 2024 Financial Results

      LAFAYETTE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and nine months ended September 30, 2024. Operational highlights (all dollar amounts are USD; comparisons are to the period ended September 30, 2023 unless otherwise noted): Net revenues increased 17.4% for the quarter ended September 30, 2024 to $58.0 million, setting another Company record, and increased 5.5% sequentially over the second quarter ended June 30, 2024. Excluding acquired revenue of $1.1 million

      11/6/24 4:45:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Third Quarter 2024 Earnings Conference Call Details

      LAFAYETTE, La., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its third quarter 2024 earnings conference call on Thursday, November 7, 2024, at 12:00 p.m. EST. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=qSIpA5NC Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.

      10/22/24 8:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Record Second Quarter 2024 Financial Results

      LAFAYETTE, La., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended June 30, 2024 reached a new Company record of $55.0 million, representing an increase of $11.7 million, or 27%, over net revenues reported for the comparable quarter ended June 30, 2023. This represents 9% sequential growth in revenue over the first quarter ended March 31, 2024. Ne

      8/7/24 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Date and Time for Conference Call

      LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 8, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 888-437-3179 (US Toll-Free)+1 862-298-0702 (International) Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Wednesday, August 7, 2024. Live Audio Webcast: https://event.choruscall.co

      7/24/24 9:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces First Quarter 2024 Financial Results

      LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2024 were $50.6 million, representing an increase of $11.0 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2023. Net income for the quarter ended March 31, 2024 totaled $1.6 million. Adjusted EBITDA for the quarter ended March 31, 2024 totaled $10

      5/6/24 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Date and Time for Conference Call

      LAFAYETTE, La., April 23, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Tuesday, May 7, 2024 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1 201-689-8451 (International) Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a qualified caller, please e-mail [email protected] by 12:00 p.m. ET Monday, May 6, 2024. Live Audio Webcast: https://event.choruscall.com/mediafr

      4/23/24 9:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Smokoff Timothy sold $91,364 worth of shares (11,865 units at $7.70), decreasing direct ownership by 13% to 79,786 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      3/17/25 4:42:59 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Chief Operating Officer Zehnder William Todd converted options into 35,791 shares, covered exercise/tax liability with 8,147 shares and returned $74,089 worth of shares to the company (8,948 units at $8.28), increasing direct ownership by 7% to 273,973 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:28:06 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Chief Financial Officer Fitzgerald Trae converted options into 13,060 shares, covered exercise/tax liability with 2,962 shares and returned $27,034 worth of shares to the company (3,265 units at $8.28), increasing direct ownership by 9% to 82,994 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:27:56 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • General Counsel Trahan Jeremy converted options into 14,366 shares, covered exercise/tax liability with 3,841 shares and returned $29,742 worth of shares to the company (3,592 units at $8.28), increasing direct ownership by 49% to 21,166 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:27:45 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Vice President of Sales Cambre Jerome returned $23,788 worth of shares to the company (2,873 units at $8.28), converted options into 11,492 shares and covered exercise/tax liability with 2,582 shares, increasing direct ownership by 7% to 89,071 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:27:34 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Chief Medical Officer Frazier William converted options into 3,113 shares, covered exercise/tax liability with 693 shares and returned $6,442 worth of shares to the company (778 units at $8.28), increasing direct ownership by 2% to 69,450 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:27:23 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Chief Executive Officer Hoyt Casey returned $109,842 worth of shares to the company (13,266 units at $8.28), converted options into 53,062 shares and covered exercise/tax liability with 13,578 shares, increasing direct ownership by 11% to 260,600 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:27:13 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • President Moore Michael converted options into 35,791 shares, covered exercise/tax liability with 8,147 shares and returned $74,089 worth of shares to the company (8,948 units at $8.28), increasing direct ownership by 12% to 177,433 units (SEC Form 4)

      4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/31/25 3:27:02 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: Chief Financial Officer Fitzgerald Trae converted options into 5,405 shares and covered exercise/tax liability with 1,843 shares, increasing direct ownership by 5% to 76,161 units (SEC Form 4)

      4/A - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/23/25 5:45:22 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Amendment: President Moore Michael converted options into 18,979 shares and covered exercise/tax liability with 5,761 shares, increasing direct ownership by 9% to 157,737 units (SEC Form 4)

      4/A - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

      1/23/25 5:45:12 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

      LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment ("Lehan"), a healthcare company offering home medical equipment with specialties in respiratory care and women's health. "Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women's health and a deep commitment to community engagement," said Viemed Chief

      5/6/25 8:30:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

      LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand Home

      4/2/24 9:00:00 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

      LAFAYETTE, La., June 13, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced the voting results from its annual general meeting of shareholders held on June 13, 2023 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 27,309,147, representing 71.33% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's m

      6/13/23 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

      LAFAYETTE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a home medical equipment supplier and the nation's largest independent provider of ventilation that provides post-acute respiratory care services, today announced the voting results from its annual general meeting of shareholders held on June 9, 2022 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 25,092,560, representing 63.86% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of D

      6/9/22 5:00:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Viemed Healthcare Announces Voting Results From Its Annual & Special Meeting of Shareholders

      LAFAYETTE, La., June 10, 2021 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO and NASDAQ:VMD), a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, today announced the voting results from its annual and special meeting of shareholders held on June 10, 2021 (the “Meeting”) in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 25,380,544, representing 64.13% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company’

      6/10/21 4:30:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Viemed Healthcare with a new price target

      RBC Capital reiterated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $9.00 from $13.00 previously

      11/3/21 9:01:34 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Royal Bank of Canada initiated coverage on Viemed Healthcare with a new price target

      Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

      3/11/21 8:08:09 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • RBC Capital initiated coverage on Viemed Healthcare with a new price target

      RBC Capital initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

      3/5/21 8:11:16 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • Royal Bank of Canada initiated coverage on Viemed Healthcare

      Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform

      3/5/21 7:30:38 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care

    Viemed Healthcare Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      2/15/24 9:27:58 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      2/15/24 9:27:32 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G filed by Viemed Healthcare Inc.

      SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      2/14/24 4:51:42 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      2/13/24 9:52:36 AM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G filed by Viemed Healthcare Inc.

      SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      2/2/24 2:18:06 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      5/18/23 5:21:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      2/8/23 3:09:29 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      10/18/22 3:44:55 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G filed by Viemed Healthcare Inc.

      SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      7/8/22 4:57:00 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

      SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

      6/28/22 5:05:26 PM ET
      $VMD
      Misc Health and Biotechnology Services
      Health Care